Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LACOSAMIDA ADROIQ 10 MG/ML SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LACOSAMIDA ADROIQ 10 MG/ML SOLUCION PARA PERFUSION

Approved

STANDARD

LACOSAMIDA ADROIQ 10 MG/ML SOLUCION PARA PERFUSION

Extrovis Eu Kft.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Nov 22, 2023
Approval ID: 933ed6e329931399
Company: Extrovis Eu Kft.
Type: Standard

Approval Details

Approval Id: 933ed6e329931399
Drug Cima Aemps Name: LACOSAMIDA ADROIQ 10 MG/ML SOLUCION PARA PERFUSION
Register Number: 1231732001
Holder Company Name: Extrovis Eu Kft.
Marketing Company Name: Zentiva Spain S.L.
Authorization Date: 2023-11-22
Dosage Form: SOLUCIÓN PARA PERFUSIÓN
Dose: 10 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Extrovis Eu Kft.

Active Ingredients

LACOSAMIDA

10 mg/ml

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 22, 2023

Approval ID

933ed6e329931399

Type

Standard

Back to CIMA-AEMPS Approvals